SOX2 and cancer: Together with previous work from our laboratory [19,20,21,22], the findings presented here demonstrate that elevating SOX2 in seven types of human cancer invariably leads to growth inhibition, strongly suggesting that this is a general effect of elevated SOX2 in human cancer.